Cardiovascular Disease Awareness in Rheumatoid Arthritis and Knee Osteoarthritis

NCT ID: NCT07056608

Last Updated: 2025-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-06-01

Study Completion Date

2025-09-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cardiovascular diseases (CVD) are still the most common cause of death. For these reasons, individuals, especially those with chronic diseases, need to be aware of CVD. CVD is also a significant cause of morbidity and mortality in rheumatoid arthritis (RA). This study aimed to compare CVD awareness in RA and knee osteoarthritis (KOA).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients who apply to our Physical Medicine and Rehabilitation clinic and are followed up with the diagnosis of RA and (KOA) will be screened. Demographic values such as age, gender, height, weight, smoking and alcohol use, diseases and medications used, cardiovascular disease awareness will be assessed with the Cardiovascular Disease Risk Factors Knowledge Level (CARRF-KL), exercise levels with the International Physical Activity Questionnaire (IPAQ), and nutritional habits with the Nutrition Attitude Scale (NAS). Cardiovascular risk calculation will be made with the Framingham Risk Score. It will also be ensured that patients with high risk are directed to the relevant branches. In addition, the Timed Up and Go Test (TUG), which is a prognosis indicator for cardiovascular diseases, will be performed. All surveys will be filled out in both groups and compared in terms of cardiovascular risk awareness.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Disease Risk Rheumatoid Arthritis (RA) Knee Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Rheumatoid arthritis

Female patients aged 40 years and over with rheumatoid arthritis

No interventions assigned to this group

Knee osteoarthritis

Female patients aged 40 years and over diagnosed with knee osteoarthritis

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 40 and over
* Patients diagnosed with rheumatoid arthritis or osteoarthritis
* Volunteering to participate in the study

Exclusion Criteria

* Patients who cannot ambulate
* Patients who cannot be evaluated due to cognitive reasons
* Those who are not receiving enteral nutrition or whose general condition is so poor that they cannot exercise
Minimum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sisli Hamidiye Etfal Training and Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Selda Çiftci

Medical Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Banu Kuran, Professor, Medical Doctor

Role: STUDY_DIRECTOR

Şişli Hamidiye Etfal Training and Research Hospital, İstanbul, Turkey

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Şişli Hamidiye Etfal Training and Research Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5.20.2025/approval no:4866

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Patient Education and Rheumatoid Arthritis
NCT07170371 ACTIVE_NOT_RECRUITING NA